1. Detecting actionable PIK3CA mutations through next-generation sequencing (NGS) in hormone receptor positive (HR+)/HER2-negative advanced/metastatic breast cancer (MBC): a real-life experience. (November 2022) Authors: Caldart, A.; Fiorio, E.; Zanelli, S.; Biondani, P.; Parolin, V.; Pellini, F.; Montemezzi, S.; Nottegar, A.; Caliò, A.; Zampiva, I.; Merler, S.; Mongillo, M.; Avesani, B.; Borghesani, G.; Giontella, E.; Scarpa, A.; Milella, M. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis. Issue 7 (July 2016) Authors: Nottegar, A.; Veronese, N.; Senthil, M.; Roumen, R.M.; Stubbs, B.; Choi, A.H.; Verheuvel, N.C.; Solmi, M.; Pea, A.; Capelli, P.; Fassan, M.; Sergi, G.; Manzato, E.; Maruzzo, M.; Bagante, F.; Koç, M.; Eryilmaz, M.A.; Bria, E.; Carbognin, L.; Bonetti, F. Journal: European journal of surgical oncology Issue: Volume 42:Issue 7(2016:Jul.) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗